Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2070-2025

The HemoCue Glucose 201 Microcuvettes are designed for use with the HemoCue Glucose 201 (or DM) Analyzer with plasma conversion that multiplies the measured whole blood glucose value by a factor of 1.112 and displays a plasma equivalent glucose result. HemoCue Glucose 201 Microcuvettes are available in individual packages or in vials. The box contains 4 vials with 25 microcuvettes in each vial.

Publicado el 9 de julio de 2025 · Inicio del retiro: 12 de mayo de 2025

Resumen

FDA registra el retiro Z-2070-2025 de dispositivos médicos de Clase II, publicado el 9 de julio de 2025 e iniciado el 12 de mayo de 2025. Empresa responsable: HemoCue AB; Estado: En curso; Cantidad reportada: 4 Boxes; Lote: UDI-DI: 07311091107060, Lot: 2501708 (Only 4 boxes within specific McKesson Shipment). La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Glucose microcuvettes experienced transit time outside of limits, so stability through the whole microcuvette lifetime can no longer be guaranteed. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency, and purity of the product. This failure could increase the probability of an incorrect test result or a delayed test result.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
HemoCue AB
Distribuidor
US Nationwide distribution in the state of AR.
Lote
UDI-DI: 07311091107060, Lot: 2501708 (Only 4 boxes within specific McKesson Shipment)
Clasificación de riesgo
Class II
Área (FDA)
device
País
Sweden

Retiros relacionados

Preguntas sobre este retiro

¿The HemoCue Glucose 201 Microcuvettes are designed for use with the HemoCue Glucose 201 (or DM) Analyzer with plasma conversion that multiplies the measured whole blood glucose value by a factor of 1.112 and displays a plasma equivalent glucose result. HemoCue Glucose 201 Microcuvettes are available in individual packages or in vials. The box contains 4 vials with 25 microcuvettes in each vial. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2070-2025 el 9 de julio de 2025. Peligro reportado: Glucose microcuvettes experienced transit time outside of limits, so stability through the whole microcuvette lifetime can no longer be guaranteed. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency, and purity of the product. This failure could increase the probability of an incorrect test result or a delayed test result.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter